Astellas Pharma Inc's ticker is ALPMY and the CUSIP is 04623U102. A total of 10 filers reported holding Astellas Pharma Inc in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $628,000 | -49.5% | 38,344 | -54.2% | 0.34% | -16.7% |
| Q4 2014 | $1,243,000 | +86.6% | 83,750 | +86.8% | 0.41% | +16.6% |
| Q3 2014 | $666,000 | -47.6% | 44,841 | -53.6% | 0.35% | -30.2% |
| Q2 2014 | $1,270,000 | +3.1% | 96,674 | +16.8% | 0.50% | +12.6% |
| Q1 2014 | $1,232,000 | -0.9% | 82,780 | -1.2% | 0.44% | +9.1% |
| Q4 2013 | $1,243,000 | – | 83,750 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RENAISSANCE GROUP LLC | 1,006,415 | $15,080,000 | 0.60% |
| Henry James International Management Inc. | 18,078 | $271,000 | 0.12% |
| QUADRANT CAPITAL GROUP LLC | 27,557 | $407,000 | 0.07% |
| SCOUT INVESTMENTS, INC. | 210,640 | $3,156,000 | 0.06% |
| Aristotle Capital Management, LLC | 442,510 | $6,631,000 | 0.04% |
| BOSTON ADVISORS LLC | 43,966 | $658,000 | 0.03% |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 2,560,399 | $38,329,000 | 0.03% |
| GLENMEDE TRUST CO NA | 306,283 | $4,588,000 | 0.02% |
| FULTON BANK, N.A. | 14,909 | $223,000 | 0.02% |
| Front Row Advisors LLC | 1,101 | $16,000 | 0.01% |